In addition, the detection of other autoantibodies and the transient elevation in anti-GAD antibody titers during immunotherapy imply that anti-GAD antibodies may not directly trigger the pathogenesis of encephalitis/encephalopathy. The gene discussed is GAD1; the disease is viral encephalitis.